Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01167
|
|||||
| Drug Name |
Menadione
|
|||||
| Synonyms |
Aquakay; 1,4-Naphthalenedione, 2-methyl-,radical ion(1-); 2-Methyl-1,4-naftochinon; 2-Methyl-1,4-naftochinon [Czech]; 2-Methyl-1,4-naphthalenedione; 2-Methyl-1,4-naphthochinon; 2-Methyl-1,4-naphthochinon [German]; 2-Methyl-1,4-naphthoquinone; 2-Methylnaphthoquinone; 2-methyl-1,4-naphthoquinone, 5; 2-methylnaphthalene-1,4-dione; 3-Methyl-1,4-naphthoquinone; 58-27-5; Aquakay; Aquinone; Ascorbic acid/menadione; Hemodal; Juva-K; K-Thrombyl; K-Vitan; Kaergona; Kanone; Kappaxan (VAN); Kappaxin; Kappaxin (TN); Karcon; Kareon; Kativ-G; Kayklot; Kaykot; Kayquinone; Kipca; Kipca, oil soluble; Kipca-Oil Soluble; Klottone; Klottone;Koaxin; Koaxin; Kolklot; M0373; Memodol; Menadion; Menadione (K3); Menadione (USP); Menadione [USAN:BAN]; Menadione semiquinone; Menadionum; Menaphthon; Menaphthone; Menaphtone; Menaquinone 0; Methyl-1,4-naphthalenedione; Methyl-1,4-naphthoquinone; Methylnaphthoquinone; Mitenon; Mitenone; Panosine; Prokayvit; Synkay; Thyloquinone; Triglycyl-lysine-vasopressin; Usaf; Usaf ek-5185; VK3; Vicasol; Vitamin K 3; Vitamin K0; Vitamin K2(0); Vitamin K3; Vitamin K3 : 2-Methyl-1,4-naphthoquinone; Vitamin-K3; menadione
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Vitamin K deficiency [ICD11: 5B59] | Approved | [1] | |||
| Prostate cancer [ICD11: 2C82] | Approved | [1] | ||||
| Therapeutic Class |
Vitamins
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C11H8O2
|
|||||
| Canonical SMILES |
CC1=CC(=O)C2=CC=CC=C2C1=O
|
|||||
| InChI |
InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3
|
|||||
| InChIKey |
MJVAVZPDRWSRRC-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 58-27-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 172.18 | Topological Polar Surface Area | 34.1 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
2.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321386
, 10528213
, 11112142
, 11120351
, 11120839
, 11121327
, 11335255
, 11341462
, 11360494
, 11361645
, 11364122
, 11364936
, 11366684
, 11367498
, 11369246
, 11370060
, 11373099
, 11374123
, 11375660
, 11377408
, 11378230
, 11408337
, 11446754
, 11461466
, 11466487
, 11467607
, 11485003
, 11486213
, 11487047
, 11489010
, 11492537
, 11495042
, 11532917
, 11533196
, 12016111
, 14772598
, 22389508
, 24871411
, 3133921
, 607330
, 6380040
, 70547
, 7751
, 7849394
, 7891061
, 8136904
, 8149919
, 8152543
, 853737
, 853809
|
|||||
| ChEBI ID |
ChEBI:28869
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | The Drugs.com International Drug Name Database: menadione | |||||
| 2 | The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3279-86. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.